{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:05:52Z","timestamp":1779249952228,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["MCI grant P30 CA016672"],"award-info":[{"award-number":["MCI grant P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Extrauterine mesonephric-like carcinoma (ExUMLC) is a rare female genital tract tumor associated with advanced stage disease and distant recurrences. Although there is a histologic and mutational overlap with extrauterine low grade endometrioid carcinoma (ExULGEC), the distribution of the main components of the tumor microenvironment (TME) in these two neoplasms is not known. In this study we evaluated the clinicopathologic characteristics and the main lymphocyte populations in different compartments of the TME in cases of ExUMLC (18) and ExULGEC (17) - diagnosed at a single institution. A multiplex immunofluorescence panel including CD3, CD4, CD8, CD20, CD56, pancytokeratin, Foxp3, and Ki-67 was applied in all cases. The median age of ExUMLC was 60.5 years (range: 37\u201369 years), while in ExULGEC was 53 years (range: 22\u201383 years). The tumor compartment and total area analyzed of ExUMLC were significantly enriched in CK\u2009+\u2009Ki-67\u2009+\u2009cells [(tumor: median 478 vs. 37.4 cells\/mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.029) and (total: median 304.5 vs. 33.2 cells\/mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.044)], CD3\u2009+\u2009CD4+ T-cells [(tumor: median 0.6 vs. 0 cells\/mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01) and (total: median 2.6 vs. 0.3 cells\/mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.022)], and CD3\u2009+\u2009CD4+Foxp3\u2009+\u2009T-cells [(tumor: median 0 vs. 0 cells\/ mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.035) and (total: median 0.8 vs. 0 cells\/mm\n                    <jats:sup>2<\/jats:sup>\n                    ,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007)]. Importantly, distances from CK\u2009+\u2009to CD3\u2009+\u2009CD4+ cells were also significantly lower in the ExUMLC group compared to ExULGEC. ExUMLC has a unique lymphoid microenvironment characterized by an overall low concentration of lymphocytes with a higher concentration of CD4\u2009+\u2009T-cells and classic Tregs when compared to ExULGEC. This \u201ccold\u201d and immunosuppressive TME may be implicated in the more aggressive biology, and potentially pose a challenge for targeted treatment options in patients with ExUMLC.\n                  <\/jats:p>","DOI":"10.1007\/s00428-026-04566-3","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:08:19Z","timestamp":1779246499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extrauterine mesonephric-like carcinoma: a tumor with a cold lymphocytic immune microenvironment"],"prefix":"10.1007","author":[{"given":"Mario L.","family":"Marques-Piubelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibelle Freitas Pinto","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrett C.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renganayaki","family":"Pandurengan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela E.","family":"Duenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin R.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saxon","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetha","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-7340","authenticated-orcid":false,"given":"Elizabeth D.","family":"Euscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4566_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/his.12895","volume":"68","author":"M McFarland","year":"2016","unstructured":"McFarland M, Quick CM, McCluggage WG (2016) Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology 68:1013\u20131020","journal-title":"Histopathology"},{"key":"4566_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","volume":"45","author":"J Pors","year":"2021","unstructured":"Pors J, Segura S, Chiu DS et al (2021) Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study. Am J Surg Pathol 45:498\u2013506","journal-title":"Am J Surg Pathol"},{"key":"4566_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/PAS.0000000000001766","volume":"46","author":"E Deolet","year":"2022","unstructured":"Deolet E, Arora I, Van Dorpe J et al (2022) Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum. Am J Surg Pathol 46:124\u2013133","journal-title":"Am J Surg Pathol"},{"key":"4566_CR4","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","volume":"42","author":"J Pors","year":"2018","unstructured":"Pors J, Cheng A, Leo JM et al (2018) A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract. Am J Surg Pathol 42:1596\u20131606","journal-title":"Am J Surg Pathol"},{"key":"4566_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/PAS.0000000000002039","volume":"47","author":"ED Euscher","year":"2023","unstructured":"Euscher ED, Marques-Piubelli ML, Ramalingam P et al (2023) Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol 47:635\u2013648","journal-title":"Am J Surg Pathol"},{"key":"4566_CR6","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753","journal-title":"Pharmacol Ther"},{"key":"4566_CR7","doi-asserted-by":"publisher","first-page":"604084","DOI":"10.3389\/fonc.2020.604084","volume":"10","author":"F Ning","year":"2020","unstructured":"Ning F, Cole CB, Annunziata CM (2020) Driving Immune Responses in the Ovarian Tumor Microenvironment. Front Oncol 10:604084","journal-title":"Front Oncol"},{"key":"4566_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","volume":"34","author":"EM da Silva","year":"2021","unstructured":"da Silva EM, Fix DJ, Sebastiao APM et al (2021) Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod pathology: official J United States Can Acad Pathol Inc 34:1570\u20131587","journal-title":"Mod pathology: official J United States Can Acad Pathol Inc"},{"key":"4566_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/PGP.0000000000000573","volume":"39","author":"WG McCluggage","year":"2020","unstructured":"McCluggage WG, Vosmikova H, Laco J (2020) Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma. Int J Gynecol Pathol 39:84\u201392","journal-title":"Int J Gynecol Pathol"},{"key":"4566_CR10","doi-asserted-by":"crossref","unstructured":"Koh HH, Park E, Kim HS (2022) Mesonephric-like adenocarcinoma of the ovary: clinicopathological and molecular characteristics. Diagnostics (Basel, Switzerland). 12","DOI":"10.3390\/diagnostics12020326"},{"key":"4566_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","volume":"42","author":"J Mirkovic","year":"2018","unstructured":"Mirkovic J, McFarland M, Garcia E et al (2018) Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. Am J Surg Pathol 42:227\u2013233","journal-title":"Am J Surg Pathol"},{"key":"4566_CR12","doi-asserted-by":"publisher","first-page":"100652","DOI":"10.1016\/j.gore.2020.100652","volume":"34","author":"DI Lin","year":"2020","unstructured":"Lin DI, Shah N, Tse JY et al (2020) Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin. Gynecologic Oncol Rep 34:100652","journal-title":"Gynecologic Oncol Rep"},{"key":"4566_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso A, Revandkar A, Di Mitri D et al (2014) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep 9:75\u201389","journal-title":"Cell Rep"},{"key":"4566_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejca.2017.06.016","volume":"83","author":"P Lohneis","year":"2017","unstructured":"Lohneis P, Sinn M, Bischoff S et al (2017) Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. Eur J Cancer 83:290\u2013301","journal-title":"Eur J Cancer"},{"key":"4566_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura P, Shekarian T, Alcazer V et al (2019) Cold Tumors: A Therapeutic Challenge for Immunotherapy. Front Immunol 10:168","journal-title":"Front Immunol"},{"key":"4566_CR16","doi-asserted-by":"crossref","unstructured":"Cassar E, Kartikasari AER, Plebanski M (2022) Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities. Cancers 14:5488","DOI":"10.3390\/cancers14225488"},{"key":"4566_CR17","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8\u2009+\u2009tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538\u201318543","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04566-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04566-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:08:24Z","timestamp":1779246504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04566-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":17,"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04566-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at The University of Texas MD Anderson Cancer Center (MDACC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no other sources of funding or conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}